Probable amlodipine-induced angioedema

Annals of Pharmacotherapy

Volumn 43, Issue 4, 2009, Pages 772-776

  Southward, Jessica ^a   Irvine, Elizabeth ^a   Rabinovich, Marina ^a  

^a GRADY HEALTH SYSTEM   (United States)

Author keywords

Amlodipine; Angioedema; Calcium channel blocker

Indexed keywords

AMLODIPINE; CINACALCET; CLONIDINE; DIPHENHYDRAMINE; FAMOTIDINE; FENTANYL; FOSPHENYTOIN SODIUM; HYDROCORTISONE; LABETALOL; METOPROLOL; NICARDIPINE; PROPOFOL; RANITIDINE; VALSARTAN; VANCOMYCIN; VERAPAMIL;

ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; DRUG WITHDRAWAL; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; LABORATORY TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

AMLODIPINE; ANGIOEDEMA; CALCIUM CHANNEL BLOCKERS; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; MIDDLE AGED; STROKE;

EID: 65749093446     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L527     Document Type: Article

References (18)

1. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001;24:599-606.
2. Temino VM, Peebles RS. The spectrum and treatment of angioedema. Am J Med 2008;121:282-286
3. Kaplan AP, Greavers MW. Angioedema. J Am Acad Dermatol 2005;53: 373-388
4. Losartan. DRUGDEX System. Greenwood Village, CO: Thomson Micromedex (accessed 2008 Oct 29).
5. Warner KK, Visconti JA, Tschampel MM. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Ann Pharmacother 2000;34:526-528 DOI 10.1345/aph.19294
6. Product information. Cerebyx (fosphenytoin). New York: Pfizer, June 2002.
7. Product information. Pepcid (famotidine). Deerfield, IL: Baxter Healthcare Corporation, June 2007.
8. Hedner T, Samuelsson O, Lindholm L, Andren L, Wiholm BE. Precipitation of angioedema by antihypertensive drugs. J Hypertens 1991;9: S360-1.
9. Romano A, Pietrantonio F, Garcovich A, et al. Delayed hypersensitivity to diltiazem in two patients. Ann Allergy 1992;69:31-32
10. Sadick NS, Katz AS, Schreiber TL. Angioedema from calcium-channel blockers. J Am Acad Dermatol 1989;21:132-133
11. Sauve L, Gras-Champel V, Decocq G, et al. Angioedema associated with the use of dihydropyridines (letter). Therapie 1999;54:64-65
12. Chiu AG, Newkirk KA, Davidson BJ, et al. Angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter review and an algorithm for airway management. Ann Otol Rhinol Laryngol 2001;110: 834-840
13. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245
14. Reed LK, Meng J, Joshi GP. Tongue swelling in the recovery room: a case report and discussion of postoperative angioedema. J Clin Anesth 2006;18:26-29 (Pubitemid 43767289)
15. Frigas E, Nzeako UC. Angioedema pathogenesis, differential diagnosis, and treatment. Clin Rev Allergy Immunol 2002;23:217-231
16. Pigman EC, Scott JL. Angioedema in the emergency department: the impact of angiotensin-converting enzyme inhibitors. Am J Emerg Med 1993;11:348-354
17. Mason RP, Marche P, Hintze H. Novel vascular biology of third-generation L-type calcium-channel antagonists. Arterioscler Thromb Vasc Biol 2003;23:2155-2163
18. Nakamura K, Ariyoshi N, Iwatsubo T, et al. Inhibitory effects of nicardipine to cytochrome P450 (CYP) in human liver microsomes. Biol Pharm Bull 2005;28:882-885